Wolverine Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wolverine Trading’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,500	Closed	-$216K	–	5553
2020 Q1	$216K	Buy	+7,500	New	+$209K	﹤0.01%	3606
2019 Q1	–	Sell	-12,800	Closed	-$141K	–	5642
2018 Q4	$141K	Buy	+12,800	New	+$178K	﹤0.01%	3853
2018 Q3	–	Sell	-10,900	Closed	-$198K	–	6283
2018 Q2	$198K	Hold	10,900	–	–	﹤0.01%	4388
2018 Q1	$198K	Buy	+10,900	New	+$182K	﹤0.01%	4388
2017 Q4	–	Sell	-11,300	Closed	-$209K	–	5770
2017 Q3	$209K	Sell	11,300 -19,700	-64%	-$329K	﹤0.01%	3751
2017 Q2	$530K	Buy	31,000 +7,700	+33%	+$117K	﹤0.01%	2377
2017 Q1	$308K	Buy	+23,300	New	+$365K	﹤0.01%	2990
2016 Q4	–	Sell	-15,200	Closed	-$173K	–	5458
2016 Q3	$173K	Sell	15,200 -2,000	-12%	-$23.5K	﹤0.01%	3921
2016 Q2	$182K	Buy	+17,200	New	+$177K	﹤0.01%	3348

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wolverine Trading's MNTA Position: Q3 2018 in Review

Wolverine Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2018, closing a stake of 15,336 shares — an estimated $278K sold.

Wolverine Trading first reported a position in MNTA in Q2 2016 and held it in 3 quarters. The position peaked at $278K in Q2 2018. 159 funds tracked by Wall St. Rank hold MNTA as of Q3 2018.

Wolverine Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Wolverine Trading sold 15,336 Momenta Pharmaceuticals, Inc. shares in Q3 2018, an estimated $278K.
Wolverine Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
Wolverine Trading's Momenta Pharmaceuticals, Inc. position peaked at $278K in Q2 2018.
159 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.